Michael Feld - Nov 26, 2024 Form 4 Insider Report for BECTON DICKINSON & CO (BDX)

Role
EVP & President, Life Sciences
Signature
Donna Kalazdy, by power of attorney from Michael Feld
Stock symbol
BDX
Transactions as of
Nov 26, 2024
Transactions value $
$0
Form type
4
Date filed
11/29/2024, 10:00 AM
Previous filing
Aug 21, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BDX Common Stock Award $0 +2.55K +38.47% $0.00 9.19K Nov 26, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDX Stock Appreciated Rights Award $0 +10K $0.00 10K Nov 26, 2024 Common Stock 10K $224.25 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.
F2 The stock appreciation rights vest in four annual installments beginning November 26, 2025.